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Abstract
There is an unresolved debate about the potential effects of financial speculation on food prices and price volatility.
Germany’s largest financial institution and leading global investment bank recently decided to continue investing
in agricultural commodities, stating that there is little empirical evidence to support the notion that the growth
of agricultural-based financial products has caused price increases or volatility. The statement is supported by a
recently published literature review, which concludes that financial speculation does not have an adverse effect on
the functioning of the agricultural commodities market. As public health professionals concerned with global food
insecurity, we have appraised the methodological quality of the review using a validated and reliable appraisal tool.
The appraisal revealed major shortcomings in the methodological quality of the review. These were particularly
related to intransparencies in the search strategy and in the selection/presentation of studies and findings; the
neglect of the possibility of publication bias; a lack of objective or rigorous criteria for assessing the scientific quality
of included studies and for the formulation of conclusions. Based on the results of our appraisal, we conclude that
it is not justified to reject the hypothesis that financial speculation might have adverse effects on food prices/price
volatility. We hope to initiate reflections about scientific standards beyond the boundaries of disciplines and call for
high quality, rigorous systematic reviews on the effects of financial speculation on food prices or price volatility.
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Background
Germany’s largest financial institution and leading global
investment bank continues investing in agricultural
commodities [1], stating that “there is little empirical
evidence to support the notion that the growth of
agricultural-based financial products has caused price
increases or volatility” [2]. The bank’s statement is
supported by a literature review recently published
by researchers based in Germany at the University of
Halle-Wittenberg and the ‘Leibniz Institute for Agricultural
Development in Central and Eastern Europe’. The review,
which comprises 35 studies published between 2010 and
2012, concludes that “[..] financial speculation does not
have an adverse effect on the functioning of the agricultural
commodities market [..]. If one considers the empirical
evidence in its entirety [..], the alarm raised by civil-society
organizations must, inevitably, be regarded as false alarm.”
[3] (p.20, emphases in original). The “alarm” refers to a
campaign, launched by a broad coalition of civil society
organisations (CSOs) in Germany, which advocate for
regulation of investments in agricultural commodities,
claiming that the increase in financial products has led to
higher food prices and volatility of markets. International
medical journals have recently been a platform for similar
debates [4-6]. In Germany, this controversy is increasingly
becoming a matter of “science vs. civil society”. In an open
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letter to the Federal President of Germany, the lead authors
of the review [3], supported by 40 German scientists
and agricultural economists, have called for a more
differentiated discussion about the potential effects of
financial speculations and actively advocated against
the regulation of agricultural markets. Building their
arguments mainly upon the cited review [3], they expressed
their concern that arguments which are scientifically
not supportable had been invoked by CSOs. Although
these debates take place in a national context, any policy
implications drawn from such conclusions might have
global consequences.
Discussion
As public health professionals concerned with global food
insecurity, we have followed the increasingly controversial
public debates and read the review [3] invoked by the
scientists as proof of ‘no evidence’ for a relationship
between speculations and food prices or price volatility.
However, we find this ‘proof ’ unconvincing, at least if
the standards of evidence-based medicine (EBM) are
applied. From an EBM perspective, the appropriate
research design for a review that aims to draw the
conclusion ‘no evidence for an adverse effect of X on
Y’ is the systematic review. The rigorous standards of
the systematic review have been developed to make
transparent how research findings are derived from a
review of literature, while at the same time minimising
bias caused by selective search strategies, selective
inclusion or exclusion of literature, unsystematic extraction
and presentation of results, or subjective appraisal of
the quality or importance of research findings within the
included literature.
We have applied these standards to the above-mentioned
review [3] using AMSTAR, a structured, validated tool
for appraising the methodological quality of reviews [7].
All authors independently read and appraised the review.
In line with the usual AMSTAR procedure, the mean
(95% confidence interval, CI) of all independently estab-
lished total scores of the appraisal was interpreted as
reflecting the quality of the review in question. Mean
inter-item correlations were calculated and inter-rater
reliability regarding the absolute agreement on the total
scores was assessed by the intraclass correlation (ICC)
derived from a two-way random effects model [8] using
SPSS 16.0.
The review was rated an average total score of 1.71
(95% CI: 0.83 - 2.59) in the AMSTAR appraisal out of
a maximum achievable score of 11. Mean inter-item
correlations were moderate (0.73) and inter-rater reliability
on the total score was very high (ICC=0.94, 95% CI:
0.87 - 0.98).
Figure 1 illustrates how the review [3] scored in each
single dimension of the appraisal tool. The largest
discrepancy between the EBM standards and the review
[3] were related to: intransparencies in the search strategy
(AMSTAR3) and in the selection/presentation of studies
and findings (AMSTAR2&5); the neglect of the possibility
20 40 60 80 100
Reviewer ratings (%)
AMSTAR 11 − Was the conflict of interest stated?
AMSTAR 10 − Was the likelihood of publication bias assessed?
AMSTAR 9 − Were the methods used to combine the findings of studies appropriate?
AMSTAR 8 − Was the scientific quality of the included studies used appropriately in formulating conclusions?
AMSTAR 7 − Was the scientific quality of the included studies assessed and documented?
AMSTAR 6 − Were the characteristics of the included studies provided?
AMSTAR 5 − Was a list of studies (included and excluded) provided?
AMSTAR 4 − Was the status of publication (i.e. grey literature) used as an inclusion criterion?
AMSTAR 3 − Was a comprehensive literature search performed?
AMSTAR 2 − Was there duplicate study selection and data extraction?
AMSTAR 1 − Was an `a priori´ design provided?
Yes No
Can’t tell Not applicable
Figure 1 Ratings on each of the 11 items of the AMSTAR appraisal tool (N=7 raters).*Percentages refer to ratings of 7 raters who
independently appraised Will et al. [3] using the AMSTAR appraisal tool.
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of publication bias (AMSTAR10); a lack of disclosure of
potential conflicts of interest (AMSTAR11); and most
notably a lack of objective or rigorous ‘a priori’ criteria
for assessing the scientific quality of included studies
and for the formulation of conclusions (AMSTAR7-8)
(Figure 1). Excluding indicators rated ‘not applicable’
(which was the case only for AMSTAR9) did not
change the mean total scores/ICC of the analysis.
Due to the fact that all initial assessments fed into the
review without any post-hoc ‘corrections’, it is principally
possible that false positive or false negative judgements
affected our results (see Additional file 1, p.3). However,
as Figure 1 and the high ICC suggest, such minor
discrepancies do not considerably affect the overall
judgement on the quality of the review.
Not all AMSTAR indicators were easily transferable
to the review [3] and members of the appraisal team
had to make individual judgements. It is important to
note, however, that the AMSTAR standards, which mainly
refer to statistical tests, were not applied rigidly but rather
flexibly in this context, with explicit considerations about
the applicability of each item and the rationale behind (see
Additional file 1, pp.1-2). Moreover, the high inter-rater
reliability (ICC) shows that the AMSTAR tool can be
meaningfully applied for assessing the methodological
quality of a review regardless of its scientific discipline.
Informed by the principles of EBM and in an attempt
to improve the methodological and reporting quality of
economic reviews, similar standards have just recently
been formulated in the field of economics by the ‘Meta-
Analysis of Economics Research Network’ (MAER) [9].
The rationale for using the AMSTAR guideline instead
of the one tailored for the field of economics was that:
(i) AMSTAR has been rigorously validated (which is not
the case for many appraisal checklists, including the
MAER guideline as far the authors can judge from the
literature [9]); (ii) the MAER guideline does not provide
an overall summary score (which makes it difficult
to aggregate judgements about quality) and puts an
emphasis on meta-analyses and pooling techniques
(which, however, does not lessen its applicability to the
review in question); (iii) despite the overlap of the
MAER standards with some of the AMSTAR principles,
we felt more comfortable using a ‘lens’ from our own
research background to make a judgement about a study
from a different field.
Conclusion
Given the obvious methodological shortcomings of the
review [3] (Figure 1), we conclude that it is not justified
to reject the hypothesis that financial speculation has
adverse effects on food prices/price volatility. If ‘financial
speculation’ was a drug, and ‘rising food prices’ or ‘price
volatility’ its potential adverse effect, the current ‘proof ’
[3] would be insufficient to falsify critical assertions about
these effects when the standards of our discipline [7] are
applied. These standards [7,9] are also applicable to reviews
of observational studies [10] and they are essential for
conclusions such as ‘no evidence for a relation between
X and Y’ to be drawn [3]. We hope to initiate reflections
about scientific standards beyond the boundaries of
disciplines and encourage researchers to tap the full
potential of systematic reviews of observational studies
in producing evidence relevant for policymakers [10].
We therefore call for high quality, rigorous systematic
reviews on the effects of financial speculation on food
prices/price volatility to address this important global
health topic.
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